WELCOME

WELCOME REMARKS

Conference Co-Chairs

Maarten Meulenbelt, Partner, Sidley 

Dr. Oliver Sude, Deputy Secretary General and Legal Counsel, EUCOPE

Hot Topics in CJEU LITIGATION

Vincenzo Salvatore, Former Head of Legal Service, European Medicines Agency

SESSION CHAIR: Anne Robert, Partner, Sidley

Hot Topics: The EU HTA Regulation

Dr. Ruta Janeckaite, HTA Legal Officer, European Commission

SESSION CHAIR: Matias Olsen, Senior Manager, Public Affairs and Policy, EUCOPE

THE commission's Pharma policy – overview

Ioana-Maria Gligor, Head of Unit, Secretariat-General, European Commission

Kristof Bonnarens, Policy Coordinator, European Commission

SESSION CHAIR: Maarten Meulenbelt, Partner, Sidley

THE Pharma Review – State of play discussion with eucope and efpia

Kristine Peers, General Counsel, EFPIA

Stefano Romanelli, Senior Government Affairs Manager, EUCOPE

SESSION CHAIR: Charlotte Ryckman, Europe Head, Clinical R&D and Regulatory Legal, AbbVie 

EU COMPETITION POLICY AND ENFORCEMENT TRENDS FOR 2025 

Michele Piergiovanni, Head of Unit and Acting Director, Competition, European Commission

Angélique de Brousse, Senior Legal Counsel, Competition EMEA, Johnson&Johnson 

SESSION CHAIR: Anne Robert, Partner, Sidley

EU shortages policy and the anticipated Critical Medicines Act

Hugues Malonne, Chief Executive Officer, Federal Agency for Medicines and Health Products

Dr. Chris Boyle, Partner, Sidley

SESSION CHAIR: Dr. Seán Byrne, Senior Manager, Legal and Regulatory Affairs, EUCOPE

EUROPEAN HEALTH DATA SPACE REGULATION – THE STATE OF PLAY

Martin Dorazil, Deputy Head of Unit, Digital Health, European Commission

Markus Kalliola, Programme Director, The Finnish Innovation Fund Sitra

Tapani Piha, Senior Advisor, Ministry of Health, Finland 

Josefine Sommer, Partner, Sidley

SESSION CHAIR: Leander Vranken, Senior Policy Officer, EUCOPE

CLOSING REMARKS